Combination Therapy: Intermittent Sorafenib With Bevacizumab Yields Activity and Decreased Toxicity

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6605514
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Phase I Trial of FOLFIRI in Combination With Sorafenib and Bevacizumab in Patients With Advanced Gastrointestinal Malignancies.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Increased Antitumor Activity of Bevacizumab in Combination With Hypoxia Inducible Factor-1 Inhibition

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

P3-027Liver Cirrhosis Associated With Paclitaxel and Bevacizumab Combination Therapy in a Metastatic Breast Cancer Patient

Annals of Oncology
MedicineOncologyHematology
2018English

Toxicity of Locoregional Radiotherapy in Combination With Bevacizumab in Patients With Non-Metastatic Breast Cancer (TOLERAB): Final Long-Term Evaluation

PLoS ONE
Multidisciplinary
2019English

Gastric Cancer Combination Therapy: Synthesis of a Hyaluronic Acid and Cisplatin Containing Lipid Prodrug Coloaded With Sorafenib in a Nanoparticulate System to Exhibit Enhanced Anticancer Efficacy and Reduced Toxicity

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Contraindicated Use of Bevacizumab and Toxicity in Elderly Patients With Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

Alginate Hydrogel Improves Anti-Angiogenic Bevacizumab Activity in Cancer Therapy

European Journal of Pharmaceutics and Biopharmaceutics
MedicineBiotechnologyPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy